Vivo Ventures aims for Asia investment with $275M fund
Vivo Ventures plans its first in Asian life-science investments now that it has closed a new fund, VentureWire is reporting (subscription required). The Palo Alto, Calif., outfit, formerly known as BioAsia Investments due to its former association with Asian investors, just closed a $275 million healthcare fund, its sixth.
From the VentureWire story:
Vivo expects to invest this fund in 14 to 18 companies, with a particular emphasis on those with drugs or medical devices in clinical… Continue Reading
Kleiner hires Asian medical marketing expert, James Li
Big-name Silicon Valley venture capital firm Kleiner Perkins has hired as partner a former marketing director of Merck & Co with expertise in Asia.
The appointment, first reported by VentureWire (sub required) this morning, is significant because the partner, James Li (see bio here), will be spending most of his time in China, another sign that Kleiner is taking the region more seriously. Not long ago, the firm has been skeptical of the worth of investing… Continue Reading